KeithMagnusSigelMD
Infectious Disease • New York, NYAssistant Professor, Medicine, Icahn School of Medicine at Mount Sinai
Dr. Sigel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Pl
New York, NY 10029Phone+1 212-659-8551Fax+1 212-731-5220
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 2009 - 2011- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2006
University of North Carolina at Chapel Hill School of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2004 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014
- Diabetes Care Recognition Health Care Incentives Improvement Institute
Clinical Trials
- Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study Start of enrollment: 2023 Mar 22
Roles: Contact, Principal Investigator
- A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV Start of enrollment: 2020 Jul 27
Roles: Contact
Publications & Presentations
PubMed
- 1594 citationsAn inflammatory cytokine signature predicts COVID-19 severity and survival.Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, Noam D. Beckmann, Sharon Nirenberg
Nature Medicine. 2020-08-24 - 11 citationsThe other side of screening: predictors of treatment and follow-up for anal precancers in a large health system.Richard Silvera, Tyler Martinson, Michael M. Gaisa, Yuxin Liu, Ashish A. Deshmukh
AIDS. 2021-05-19 - 16 citationsComparing Anal Cancer Screening Algorithms Using Cytology and Human Papillomavirus DNA Testing in 3 High-Risk Populations.Michael M. Gaisa, Keith Sigel, Ashish A. Deshmukh, Volha Lenskaya, Courtney A Chan
The Journal of Infectious Diseases. 2021-09-01
Journal Articles
- Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs DataRavi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
- HPV Genotypes Predict Progression of Anal Low-Grade Squamous Intraepithelial LesionsMichael M Gaisa, Yuxin Liu, Keith Sigel, The Journal of Infectious Diseases
Press Mentions
4 Recent Cancer Care PartnershipsAugust 13th, 2021- Mount Sinai Leads $4m Study Investigating Anal Cancer Screening in High-Risk Women with Previously Diagnosed HPV InfectionAugust 11th, 2021
- Mount Sinai Awarded More Than $4 Million to Evaluate Anal Cancer Screening in High-Risk WomenAugust 10th, 2021
- Join now to see all
Grant Support
- Optimizing Lung Cancer Treatment in HIV InfectionNational Cancer Institute2017–2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
